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Missing values are common in health research and omitting participants with missing data often leads to loss of
statistical power, biased estimates and, consequently, inaccurate inferences. We critically reviewed the challenges posed
by missing data in medical research and approaches to address them. To achieve this more efficiently, these issues were
analyzed and illustrated through a systematic review on the reporting of missing data and imputation methods
(prediction of missing values through relationships within and between variables) undertaken in risk prediction studies of
undiagnosed diabetes. Prevalent diabetes risk models were selected based on a recent comprehensive systematic
review, supplemented by an updated search of English-language studies published between 1997 and 2014. Reporting
of missing data has been limited in studies of prevalent diabetes prediction. Of the 48 articles identified, 62.5% (n = 30)
did not report any information on missing data or handling techniques. In 21 (43.8%) studies, researchers opted out of
imputation, completing case-wise deletion of participants missing any predictor values. Although imputation methods
are encouraged to handle missing data and ensure the accuracy of inferences, this has seldom been the case in
studies of diabetes risk prediction. Hence, we elaborated on the various types and patterns of missing data, the
limitations of case-wise deletion and state-of the-art methods of imputations and their challenges. This review highlights
the inexperience or disregard of investigators of the effect of missing data in risk prediction research. Formal guidelines
may enhance the reporting and appropriate handling of missing data in scientific journals.
Keywords: Predictive, Preventive and Personalized Medicine, Diabetes mellitus, Risk, Guidelines, Patterns, Screening,
Modeling, Patient StratificationReview
Background
Missing values on participants’ characteristics are com-
mon in healthcare research and are often non-optimally
handled and/or reported in prediction research. Inappro-
priate handling of missing data can lead to a poor model
performance at the model development stage and mis-
labelling of the model at the external validation stage. It
is therefore recommended that in predictive research, in-
vestigators strive to examine the patterns of missing
values in their database to aid in classification of such
information, use a valid approach to dealing with the* Correspondence: apkengne@yahoo.com
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unless otherwise stated.missing data and include the description in their final re-
port [1]. Predictive research is an area in which handling
of missing data is of utmost importance. Indeed, simple
risk prediction models based upon non-invasively measured
predictors are increasingly advocated in population-based
strategies for screening prevalent undiagnosed diabetes,
particularly in low and middle income countries where un-
diagnosed diabetes is very common [2]. Accordingly, many
prevalent diabetes risk prediction models have been devel-
oped over the last decade to convey this new thinking.
Available models, however, remain specific to the popula-
tion from which they were developed, until evidence of
their good performance during external validations studies
in different settings becomes available [3].
In this paper, we critically review the patterns of miss-
ing data and approaches to dealing with them, with a
focus on predictive modeling. For illustrative purpose,l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and handled in predictive modeling, through a system-
atic review of studies on the development and/or valid-
ation of prevalent diabetes risk model. We hypothesized
that the level of reporting and extent of imputation in
studies of undiagnosed diabetes model development and
validation would be poor.Methods
Building on a recent comprehensive review article on
diabetes risk prediction models by Brown et al. 2012 [4],
additional relevant articles were identified through a
search of electronic database PubMed using the key terms
‘undiagnosed’, ‘diabetes’, ‘risk’ and ‘score’ and a manual
search through reference lists of eligible studies. We se-
lected studies aimed at developing or validating a risk
prediction model. The outcome had to be prevalent un-
diagnosed diabetes in adults (aged >18 years). Models
excluded were those of incident risk prediction or requir-
ing blood tests (on the grounds that prevalent diabetes
risk prediction aims at simple screening). The data ex-
tracted included country/setting (including its income
classification), population/ethnicity, source of data and if
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Figure 1 Workflow summarizing the selection of papers. Keywords: prsample size, age range of participants and the presence of
a discussion and action (or lack thereof) on missing data.
We aimed at providing the reader with instances of
missing data, their reporting and attempts to handle
these, as well as the challenges posed by each method.
In some instances, because of the paucity of reports on
handling missing data in studies of diabetes risk predic-
tion, we used examples from other fields for greater un-
derstanding and clarity on a topic that has not received
much attention.
Results
Overview of included studies
A total of 48 articles (26 were model development studies
and 22 were external validations) were included (Figure 1).
These are summarized in Table 1; published between 1997
and 2014 (mostly appearing in 2005–2010). The number
and combination of predictors were variable, with age,
sex, body mass index and waist circumference being the
most commonly used variables. Models were developed
and validated in 24 countries across 5 continents (none
from Africa). Participants’ ethnicity was not always clearly
stated, but number of studies included minority popu-
lations specific to locations (e.g. Asian and Black partic-
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Table 1 Characteristics of 48 included studies of undiagnosed diabetes risk prediction models


















Handling of missing data
None Percent None Deletion Imputation
Adhikari et al. [39] 2010 Validate India (L/M) / Current 551 >20 X X
Akyil et al. [40] 2014 Validate Turkey (L/M) / Current 702 / X X
Al Khalaf et al. [41] 2010 Develop Kuwaiti (L/M) Caucasian Current X 562 >20 X X
Al-Lawati et al. [16] 2007 Develop Oman (H) Caucasian Existing 4,881 >20 X X
Baan et al. [17,42] 1999 Develop Netherlands (H) / Existing X 1,016 55–75 X X
Bang et al. [18] 2009 Develop USA (H) / Existing 5,258 >20 X X X
Bergmann et al. [43] 2007 Validate Germany (H) / Current 526 41–79 X X
Bindraban et al. [5] 2008 Develop Netherlands (H) Asian, Black,
Caucasian
Existing 1,434 35–60 X X
Chaturvedi et al. [19,44] 2008 Develop India (L/M) / Existing 4,044 35–64 X X
de Leon et al. [45] 2008 Develop Canary
Islands (H)
Caucasian Current 6,237 18–75 X X
de Sousa et al. [13] 2009 Develop Brazil (L/M) Multi-ethnic Existing X 1,224 >35 X X
Franciosi et al. [20] 2005 Validate Italy (H) / Existing X 1,377 55–75 X X
Gao et al. [46] 2010 Validate China (L/M) Asian Current 1,986 20–74 X X
Ginde et al. [6] 2007 Validate USA (H) Caucasian, African-
American, Hispanic
Current 604 / X X
Glumer et al. [21] 2004 Develop Denmark (H) / Existing 6,784 30–60 X X
Glümer et al. [22] 2005 Validate Australia/
Denmark (H)
/ Existing 7,079/6,270 30–60 X X
Glumer et al. [23] 2006 Validate Global Multi-ethnic Existing 29,758 / X X
Gray et al. [24] 2010 Develop UK (H) Caucasian, Asian Existing 6,186 40–75 X X
Gray et al. [25] 2013 Develop Portugal (H) / Existing 3,435
(18–94)
18–94 X X
Griffin et al. [11] 2000 Develop UK (H) Caucasian Existing 1,077 40–64 X X
Hanif et al. [47] 2008 Develop UK (H) Asian Current 435 20–75 X X
Heianza et al. [26] 2013 Develop Japan (H) Asian Existing 7,477 18–88 X X
Heikes et al. [27] 2008 Develop USA (H) Representative
of USA population
Existing 7,029 >20 X X
Heldgaard &
Griffin [48]
2006 Develop Denmark (H) / Current X 1,355 20–69 X X











Table 1 Characteristics of 48 included studies of undiagnosed diabetes risk prediction models (Continued)
Ko et al. [12] 2010 Develop China (L/M) Asian Existing 7,695 X X
Ku & Kegels [49] 2013 Validate Philippines
(L/M)
/ Current 1,789 X X
Lee et al. [29] 2012 Develop Korea (L/M) / Existing 9,602 >20 X X
Li et al. [50] 2009 Develop Germany (H) / Current 921 14–93 X X
Lin et al. [51] 2009 Validate Taiwan (H) Asian Current 2,759 >18 X X
Lindstrom et al. [14] 2003 Develop Finland (H) / Existing X 4,435 35–64 X X
Liu et al. [15] 2011 Develop China (L/M) / Existing 1,851 40–90 X X
Mohan et al. [30] 2005 Validate India (L/M) Asian Existing 2,350 >35 X X
Park et al. [31] 2002 Validate UK (H) Caucasian Existing X 6,567 39–78 X X
Rahman et al. [32] 2008 Validate UK (H) / Existing 25,639 40–79 X X
Ramachandran
et al. [33]
2005 Develop India (L/M) Asian Existing 10,003 >20 X X
Rathmann et al. [34] 2005 Validate Germany (H) Caucasian Existing 1,353 55–74 X X
Robinson et al. [7]
Rolka et al. [8]




Current 6,475 40–74 X X X
Ruige et al. [35]
Saaristo et al. [52]




Current 1,471 >20 X X
Spijkerman et al. [9] 1997 Develop Netherlands
(H)
Caucasian Existing X 2,364 50–74 X X
Ta et al. [53] 2005 Validate Finland (H) / Current
supplemented
with existing
X 2,966 45–74 X X
Tankove et al. [54] 2004 Validate UK (H) Black, Asian Existing 803 40–75 X X
Winkler et al. [38] 2010 Validate Vietnam (L/M) / Current 721 30–70 X X
Witte et al. [36] 2011 Validate Bulgaria (L/M) / Current 2,169 X X
Zhang et al. [10] 2012 Validate Hungary (L/M) / Current 68,476 >18 X X
Zhou et al. [37] 2010 Validate UK (H) Caucasian Existing 6,990 35–55 X X
Zhang et al. [10] 2014 Validate USA (H) Caucasian, Black Existing X 20,633 >20 X X
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data (30, 62.5%), from existent healthcare [11,12], gov-
ernmental organization [9,13-15] or research settings
[5,10,16-37]. The study sample sizes varied from 429
[28] to 68,476 [38]. Finally, the age of participants
ranged from 18 to 94 years.
Source of missing data in predictive research
Figure 2 summarizes reporting and handling of missing
data. The chief reasons for missing data are study design,
participant characteristics, measurements characteristics,
data collection and management and chance. These may
occur alone or simultaneously within a study, with data
missing for several different reasons acting additively.
Study design
The reviewed studies were cross-sectional. No study de-
sign can eliminate missing data, but the probability of
missing data varies across designs, with longitudinal
studies carrying a higher likelihood of missing data than
cross-sectional studies. In longitudinal studies, a greater
burden on the participants increases the likelihood of
missing data, through the duration of the study, repeated
measures, long questionnaires and painful procedures.
With lengthy and cumbersome procedures, participants
are prone to respond poorly or dropping out altogether.
Indeed, Rolka et al. had high missing percentages for the
invasive collection of a finger prick, fasting and 2-h
post-load blood collection (0.2%, 26.0% and 27.0% ofFigure 2 Graphical representation of handling of missing
data from the 48 selected studies. MI multiple imputation, SI
single imputation.missing data, respectively), as the study design required
three invasive and burdensome diagnosis tests.
Participant characteristics
Non-response to questions may be associated with per-
sonal characteristics of the participants, where the rea-
son is an inaccuracy in information processing or refusal
to provide information. Information processing may be
related to the language and comprehension levels of the
participant. Beliefs and the attitude towards the research
topic or particular item collected are important in non-
response due to refusal. All studies that reported some
form of missing data values were conducted in high in-
come countries; except three studies undertaken in
China [37,46] and Korea [29], all published after 2010.
Measurement characteristics
The collection of quantifiable predictors can lead to
missing data in a variety of ways. Observations may be
lost due to malfunctioning equipment. The complexity,
length and invasiveness of the measures may also lead to
participants opting out of particular tests (e.g. oral glu-
cose tolerance test). Finally, for predictors that are mea-
sured in a laboratory, errors in the pre-analytical sample
collection and analytical testing can result in random
missing data (e.g. incorrect blood collection tube selec-
tion or extended waiting time before analysing blood
glucose sample, where glucose is lost through glycolysis).
Demographic or behavioral information may be col-
lected via questionnaires through an interview of or self-
administration by the participant. Self-administration is
limited by the lack of supervision thus the likelihood of
respondent error, ultimately increasing missing data.
Only three articles that included self-administrated ques-
tionnaires, also reported missing data [20,35,52]. Missing
data was as high as 9% for body mass index and waist
circumference in the study by Saaristo et al. [52] and
15.3% for the oral glucose tolerance test and 15.7% for
questionnaire data in that of Franciosi et al. [20].
Data management
Poor management of data can result in the loss of data
obtained from all participants. This may be due to the
data transfer process from one format to another, such
as the exclusion of individual values due to unclear writ-
ing, unconventional answers or inadvertently missing
questionnaire items. Disorganized or poor data storage
can also result in lost data through unsystematic filing
and communication, or faulty or non-existent back up
files. Of the 17 articles reporting missing data, 13 of
these were studies using existing databases, all developed
for research [5,18,20-22,24,26,27,29,32,35-37]. Although
administrative data has its own issues, the reduced re-
sponse burden, the possibility of a large sample size and
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choice of data collection. De novo data collection re-
quires the correct preparation, validation and processing
of the survey to limit missing data. The two articles that
reported missing data above 20% were based on new
data collection [7,8].
Chance
Despite investigators’ best efforts to prevent missing data
through a study design, data collection and measurements
and subsequent management of the data, missing data can
still occur by chance. This does not produce a bias; how-
ever, large amounts of data may be missing if multiple
chance events occur which produces its own sets of prob-
lems such as reduction in statistical power [55].
Reporting of missing data
Missing data was frequently poorly handled with 62.5%
of the articles not mentioning whether missing data was
encountered and, if there was, how it was treated. Six-
teen articles (33.3%) stated the missing data percentage,
with two testing the effect on the final dataset but not
reporting missing data details [24,27]. However, from the
reporting, it is difficult to determine the type of missing
data, as this was not investigated.
Types of missing data
Missing data can be classified as ‘missing completely at
random (MCAR)’ , ‘missing at random (MAR)’, and
‘missing not at random (MNAR)’ , where the reason for
missing data differs [56-60]. Identifying the nature and
pattern of missing data allows the researcher to correctly
choose a data imputation method, which is based on the
assumptions about the patterns of missing data.
Missing completely at random
Data is MCAR where the random subset of observa-
tions missing will have similar distributions to observed
values [56]. The reasons for missing are unrelated to
characteristics or responses of the subjects. Missing
completely at random is a strict assumption and can be
tested for. Little et al. [61] provided a statistical test of
the MCAR assumption, where a significant chi-square
test indicates that the data are not MCAR. Examples of
MCAR include administrative errors or laboratory acci-
dents that occur at random.
Missing at random
Missing data is described as MAR when the missing
data is conditional. The missing observations com-
monly depend on observed characteristics not missing,
with systematic differences between the missing and
observed data [1,62]. The assumption is fulfilled if the
missing values are related only to measured, notunmeasured values. MAR examples include increased
missing data in elderly individuals, subjects from a cer-
tain region or from a different calendar time. This is il-
lustrated by Robinson et al. [7], where smoking status
was only available for selected collection sites, as this
question was added to the questionnaire during the last
phase of data collection, resulting in a large percentage
of item-missing data.
Missing not at random
Missing data that are not random are related to unob-
served participant’s characteristics [56]. This type of
missing data is problematic and imputation is not suffi-
cient. An example of MNAR is the selective non-
response by a subject, e.g. sexual orientation or weight
where the association with social image may cause
people to avoid or underestimate the answer.
Patterns of missing data
None of the selected articles on the prediction of preva-
lent diabetes risk discussed nor graphically presented pat-
terns of missing data nor offered reasons for the missing
data. In general, there are three patterns of missing data,
namely univariate, monotone and arbitrary [63].
Handling of missing data
In existing studies of diabetes risk prediction, 21 (43.8%)
stated all individual missing data were excluded from
the study analysis, conducting complete case analysis.
Two articles used simple imputation to overcome miss-
ing data [7,52] and two made use of multiple imputation
[8,25], while a single article undertook both imputation
methods [18]. Saaristo et al. stated the missing data per-
centage for the most commonly missing data (9% for
both BMI and waist circumference), both of which were
simply imputed with mean substitution [52]. Robinson
et al. used a number of deletion and imputation
methods [7]. Waist circumference (6% missing) was im-
puted with mean substitution, while family history
(13%) was dealt with by the substitution of ‘no’ for un-
answered questions. Case-wise deletion was undertaken
for all other predictors of missing data, 3.9% of partici-
pants were excluded. Finally, smoking was excluded as
a predictor all together due to the large percentage of
missing data (35.0%).
Bang et al. used a complete case analysis for predictors
with missing values as the missing data proportion was
considered ‘small’, although not stated [18]. Multiple im-
putation was done for a family history of diabetes. Per-
haps significantly, the studies with low missing data
rates or few variables with missing data undertook mul-
tiple imputation as a solution. Rolka et al. reported a full
dataset apart from only three predictors with missing
data, namely postprandial time (3.0%), fasting blood
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[8]. Finally, Gray et al. described minimal missing data
for the majority of predictors ranging from 0.1% for
current hypertension to 1.7% for smoking status, apart
from statin use (36%) [25]. The effect of missing data on
both the modeling process and the final model chosen
was assessed. Another article did not state the missing
data proportion, but rather the overall effect of missing
data, which was to underestimate the prevalence of pre-
diabetes and undiagnosed diabetes by approximately 2%
and 1.5%, respectively [27]. None of the three models
using multiple imputation stated the details of the
method [8,18,25], such as the number of imputations or
the variables included in the imputation model. We
herein discuss the key fundamental aspects of the vari-
ous methods to dealing with missing data, which were
seldom or inappropriately undertaken as mentioned
above.
Proportion of missing data and impact on the method for
handling missing data
A proportion (considered here as the proportion of
subjects having any predictors missing) of ≤0.05 is
considered the cut-off for no or simple imputation
without sacrificing results [64]. A missing data propor-
tion between 0.05 and 0.15 requires investigation of
predictor relationships. If the predictor with missing
values is unrelated to all of the other predictors, simple
imputation is considered reasonable; else, conditional
mean or stochastic regression is the minimum. Once
missing data proportion is ≥0.15, multiple imputation
becomes imperative.
Methods for dealing with missing data
Problems with simple alternatives to data imputation
Common in predictive modeling is the case-wise dele-
tion of individuals with data missing for the required
model predictors. Complete case analysis, or list-wise
deletion, removes all subjects with missing values for
any possible predictors to be used in risk models [65,66].
Alternatively, available case analysis, or pairwise dele-
tion, includes subjects with complete data for the predic-
tors to be included in the final model but who have
missing data for other predictors not considered in the
model [1]. List-wise or case-wise deletions lead to reduc-
tions in sample size, and as a consequence, a reduction
in statistical power, increase in standard error, and bias
and imprecision in the regression coefficient estimates is
introduced if the data is not MCAR [67-69]. Further-
more, when more than one prevalent diabetes risk pre-
diction models are to be validated in a new population,
it is difficult to interpret the results when the number of
subjects may vary across the analyses [1].Imputation Imputation of missing values is the process
of replacing these values with accurate parameter esti-
mates [70]. Imputation aims at predicting missing values
by obtaining values through relationships within and be-
tween variables. In general, individuals should only be
discarded if there is a missing predictor of overriding
importance that cannot be reliably imputed from other
information [1]. Table 2 details available imputation
methods, namely single and multiple imputation, and
their implementation in R statistical software. Single im-
putation (SI) includes simple imputation, conditional
mean imputation, stochastic regression imputation and
hotdecking, with each of these method having its own
advantages and drawbacks.
Multiple imputation (MI) describes the production of
multiple complete datasets derived from the initial data-
set with missing values [86]. Statistical models are used
to fill the missing data a number (m) of times to gener-
ate m complete data sets. The multiple datasets add vari-
ability, increasing accuracy for both sampling and
imputation, and the number of imputed datasets is usu-
ally set to 5 or 10 [87]. The datasets are analyzed separ-
ately using standard procedures, yielding multiple
estimates which are then combined appropriately [88].
The first stage requires an imputation algorithm, while
the combining of the analysis results of the multiple
datasets requires an alternate pooling algorithm. Imput-
ation algorithms may be univariate methods for mono-
tone missing data such as predictive mean matching
[89], propensity methods [90] or logistic regression; or
for more complicated missing data, the multiple imput-
ation by chained equations (MICE) or expectation-
maximization (EM) algorithm have been proposed. Mul-
tiple imputation methods for non-monotone missing
patterns using chained equations requires the decision of
whether to use Markov chain Monte Carlo (MCMC) or
fully conditional specification (FCS) methods. Expect-
ation-maximization has yet to become that popular in
medical applications but merits discussion and use.
Multiple imputation is time, labor and computation-
ally intensive, and in case of small amount of missing
data, researchers must decide on the use of this method
or alternative methods [62,68]. The combination of lack
of guidelines, imputer burden and perhaps lack of
knowledge makes researchers hesitant to undertake MI.
This hesitation is encouraged if MI is not going to be
carried out successfully, with the failure to combine the
final m datasets or leaving out of important predictors
in the MI model.
Dealing with missing data in validation studies The
implementation of a model in an alternative population
to that in which the model was developed requires prior
validation. Differences between the development and
Table 2 Details of imputation options
Theory Package in R
Single imputation
methods
Simple imputation In a predictor (X) which is unrelated to all other X’s, substitution
replaces all missing continuous values with the mean (or median) of
all participants who have a valid value or the mode for categorical
predictors [71].
Mean substitution is easily implemented with the
package ‘Hmisc’ of R statistical software through the
function ‘impute (x, fun =mean)’ where x is the
predictor of interest [72].
Simple imputation reduces variability and correlation estimates by
ignoring relationships between variables but assumes MCAR.
Regression coefficients are biased towards 0 (zero) since the
outcome (Y) is not considered [1].
Conditional mean
imputation
Regression imputation assumes strong relationships between the X
to be imputed and the independent X’s used in the univariable or
multivariable regression formula [1,66,73]. An imputation model is
made to predict the missing values when X is related to the other
X’s, this method is far more efficient [74-76]. Conditional mean
imputation leads to a weakening of the variance and overestimation
of the model fit and correlation estimates. The outcome (Y) should
not be included in the imputation model to prevent over
exaggeration of the strength of relationship between X and Y [1].
Conditional mean imputation can be implemented
in R through the creation of a regression model




An alternative to conditional mean imputation, stochastic regression
imputation includes a random element to the prediction of values,
highlighting the uncertainty of imputed values [73]. A random draw
is taken from the distribution of predicted values, which allows for
the inclusion of the outcome in the prediction model.
This can be implemented with the ‘mice’ package
for R via the command ‘mice.impute.norm.nob’ [77].
Hotdecking Hotdecking replaces the missing value of an individual with a
random value from a pool of individuals who are matched to the
missing individual by predictors, the ‘deck’ [78,79]. These deck
predictors may be researcher-determined or a correlation matrix may
be used to determine which the most highly correlated predictors
are. The standard error is better approximated through the hotdeck
procedure than simple imputation.
The command ‘hotdeck’ of the R package ‘VIM’ can







Multivariate normal imputation assumes a multivariate distribution
and the MCMC algorithm is used to obtain imputed values and allow
for uncertainty in the estimated model predictors [81]. MCMC describes
a group of methods that use Markov chains to generate pseudorandom
draws from probability distributions.
The command ‘mcmcNorm’ of the R package
‘MCMCglmm’ can implement MCMC approach
to multiple imputation [82].
Maximum
likelihood
The expectation-maximization (EM) algorithm, also called joint modeling,
assumes a multivariate distribution. First a set of parameter values that
produces the maximum likelihood are identified from the conditional
distribution; values that would most likely have resulted in the observed
data [77,83]. New parameter estimates are randomly drawn from a Bayesian
posterior distribution, the distribution of unobserved values conditional on
observed data [84]. Bootstrap procedures are employed to obtain standard
error estimates, correcting for bias associated with non-normality.
The package ‘Amelia’ in R implements
bootstrapping algorithms to give EM results [85].
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sibly missing altogether, hindering validation of the model.
This can be handled in a variety of ways, all which will
have an effect on model performance or final model selec-
tion. Missing predictors can be dealt with by excluding
models which contain any predictors not collected in the
study. This limits the possibility of finding an existing
model that may have suitable performance in the new
population. Alternatively, the model may be selected for
validation, but predictors in the model will be excluded
from the model formula. This method could be improved
by the substitution of a missing predictor with a reliableproxy variable, preventing model and predictor exclusion.
Of the 22 validation studies, 11 (50%) used case-wise dele-
tion of individuals or predictors in dealing with the miss-
ing data, with only a single article using mean imputation
[52] and another multiple imputation [8].
Discussion
Dealing with missing data is a complex undertaking,
which is not yet common place in medical research.
Indeed, for studies of development and validation of un-
diagnosed diabetes risk models, we found inconsistent
reporting of missing data, with investigators frequently
Masconi et al. The EPMA Journal  (2015) 6:7 Page 9 of 11ignoring or failing to handle missing data appropriately.
Despite the availability of a wide range of methods for
handling missing data, only a handful of studies used the
statistical modeling procedures. When imputation was
undertaken, the reporting of the imputation procedures
was often incomplete. Although multiple imputation is
becoming more accessible in research, only three studies
used this method with no details of the method being
provided. Despite an increased interest in recent years in
the need for understanding and appropriately handling
missing data, the scarcity of information on these issues
points to the widespread failure to understand the sig-
nificance of the problem among medical researchers,
hence the need to more formally address this issue.
In an effort to understand the lack of reporting and
correct data handling in these studies, it must be noted
that many imputation methods have mainly been devel-
oped theoretically and tested by statisticians. Medical
professionals without any experience in statistics may
struggle or chose not to undertake imputation proce-
dures for missing data. Suggested reporting guidelines
state the inclusion of the number of missing values,
along with the reasons for the missing data, and the im-
portant differences between individuals with complete
and incomplete data [91]. These guidelines can be useful
for journal editors and authors alike, as hitherto the full
impact of missing data on the research results is not
usually considered.
Our review has limitations that merit consideration.
Although we aimed to comprehensively review all papers
on development and validation of undiagnosed diabetes
risk prediction models, given that we relied on a single
review article with a simple supplemental search, we
may have missed some relevant studies. Furthermore,
MI was not widely accessible prior to 1997 (the earliest
date of publication of the included articles) so papers
published immediately after this are more likely to have
used complete case analysis or single imputation [92].Conclusions
This review highlights the inadequate reporting and
handling of missing data in prevalent diabetes prediction
research. Appropriate understanding, interpretation and
efficient handling of missing data in medical research
are essential, as incomplete data and the less than ideal
methods in dealing with this can severely affect study
estimates and other inferences in general. Publication of
formal guidelines on the uniform reporting of missing
data and methods for handling them at the analysis stage
is warranted. These guidelines should be accessible to all
levels of practitioners and researchers to allow for easy
implementation, ultimately enhancing the validity of re-
ported results in all spheres of prediction research.Competing interests
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